Attana AB (publ) provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia. The company offers analytical biosensor which allows studies on molecular interactions between proteins, DNA, and carbohydrates, as well as interactions to cells cultured; contract research services; and attana virus analytics. It serves academic institutions, biotech companies, and pharma companies. The company has a collaboration with the Linnaeus University. Attana AB (publ) was founded in 2002 and is headquartered in Sollentuna, Sweden.
Metrics to compare | ATANA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATANAPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.6x | 12.2x | −0.5x | |
PEG Ratio | −0.04 | 0.61 | 0.00 | |
Price/Book | 1.8x | 35.9x | 2.6x | |
Price / LTM Sales | 5.2x | 3.6x | 3.3x | |
Upside (Analyst Target) | - | 62.9% | 42.8% | |
Fair Value Upside | Unlock | 12.4% | 6.5% | Unlock |